Seresis®

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers

CompletedNCT02191787

Boehringer IngelheimHealthy

Start: 1998-03-31Updated: 2014-07-17

Pharmacokinetic Study of Seresis® in the Skin in Healthy Young Female Volunteers

CompletedNCT02191852

Boehringer IngelheimHealthy

Start: 1999-06-30Updated: 2014-07-17

Phase 2

Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers

CompletedNCT02191813

Boehringer IngelheimHealthy

Start: 2000-03-31Updated: 2014-07-17